Figure S2. The hazard ratio (HR) for AOM-associated antimicrobial prescriptions from the cox-regression model for each of the study birth-cohorts compared to the last vaccine non-eligible birth-cohort (2010), the reference birth-cohort. Boxes represent point estimates for HR and lines the 95% confidence intervals. (TIFF 9621 kb
Additional file 1: Supplementary Figure 1. Directed acyclic graph (DAG) on hypothesis 2: Higher reac...
Table S1. Prevalence of risk factors, OM and NP carriage among a subgroup of NP-swabbed children who...
Figure S1. Joinpoint regression of IMD HRs, all ages, years 2000â2015. (TIF 61 kb
Table S1. The proportion of linked antimicrobials associated with each diagnostic group by calendar ...
Figure S1. Proportion of primary care visits which resulted in a filled antimicrobial prescription b...
Adjusted analysis of the association of different variables with the vaccine era using linear mixed ...
Crude regression model for the association of the AB knowledge score with the likelihood to be vacci...
Figure S2. Simulated Trial of Goldblatt et al. PCV13 in a 3 + 1 Vaccinated Population. Vaccine trial...
Cumulative distribution of age at vaccination. 1st dose n = 61,119, 2nd dose n = 60,652, 3rd dose n ...
Table S1. a: Infants vaccination in National Immunization Program in the nine participating countrie...
Table S1. Medication use associated with confirmed influenza episodes by region (PDF 8 kb
Table S1. Number of RVGE and AGE cases by age group, United States, July 2001âJune 2016.a. Figure ...
Serious adverse events in infants (6–35 months), children (3–17 years), and adults (18–49 years) dur...
Medically-attended adverse events in and adults (18–49 years), children (3–17 years), and infants (6...
Identification of cases, comorbidities and control conditions; additional analyses of the incidence ...
Additional file 1: Supplementary Figure 1. Directed acyclic graph (DAG) on hypothesis 2: Higher reac...
Table S1. Prevalence of risk factors, OM and NP carriage among a subgroup of NP-swabbed children who...
Figure S1. Joinpoint regression of IMD HRs, all ages, years 2000â2015. (TIF 61 kb
Table S1. The proportion of linked antimicrobials associated with each diagnostic group by calendar ...
Figure S1. Proportion of primary care visits which resulted in a filled antimicrobial prescription b...
Adjusted analysis of the association of different variables with the vaccine era using linear mixed ...
Crude regression model for the association of the AB knowledge score with the likelihood to be vacci...
Figure S2. Simulated Trial of Goldblatt et al. PCV13 in a 3 + 1 Vaccinated Population. Vaccine trial...
Cumulative distribution of age at vaccination. 1st dose n = 61,119, 2nd dose n = 60,652, 3rd dose n ...
Table S1. a: Infants vaccination in National Immunization Program in the nine participating countrie...
Table S1. Medication use associated with confirmed influenza episodes by region (PDF 8 kb
Table S1. Number of RVGE and AGE cases by age group, United States, July 2001âJune 2016.a. Figure ...
Serious adverse events in infants (6–35 months), children (3–17 years), and adults (18–49 years) dur...
Medically-attended adverse events in and adults (18–49 years), children (3–17 years), and infants (6...
Identification of cases, comorbidities and control conditions; additional analyses of the incidence ...
Additional file 1: Supplementary Figure 1. Directed acyclic graph (DAG) on hypothesis 2: Higher reac...
Table S1. Prevalence of risk factors, OM and NP carriage among a subgroup of NP-swabbed children who...
Figure S1. Joinpoint regression of IMD HRs, all ages, years 2000â2015. (TIF 61 kb